Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 288 articles:
HTML format



Single Articles


    July 2025
  1. PAGLIARA D, Pili N, Serra PL, Schiavone L, et al
    Improving Outcomes in Immediate Prepectoral Reconstruction of Large and Ptotic Breast: The Reliability of Fifth Anterior Intercostal Artery Perforator Flap.
    Clin Breast Cancer. 2025;25:e578-e587.
    PubMed     Abstract available


  2. CABIOGLU N, Karanlik H, Ozmen V, Tukenmez M, et al
    Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study.
    Clin Breast Cancer. 2025;25:455-463.
    PubMed     Abstract available


  3. JOSHI U, Budhathoki P, Gaire S, Yadav SK, et al
    Clinical Outcomes and Prognostic Factors in Epithelial-Myoepithelial Carcinoma (EMC) of the Breast.
    Clin Breast Cancer. 2025;25:e511-e516.
    PubMed     Abstract available


  4. BUHEIRI AR, Tveskov L, Dines LM, Bagge JD, et al
    Tranexamic Acid in Breast Surgery - A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025;25:e496-e510.
    PubMed     Abstract available


    June 2025
  5. PING J, Zha H, Chen B, Gu J, et al
    Development and Validation of Preoperative Ultrasound-Based Risk Scoring Systems for Predicting Axillary Lymph Node Metastasis in Breast Cancer: A Multicenter, Retrospective Study.
    Clin Breast Cancer. 2025 Jun 15:S1526-8209(25)00177.
    PubMed     Abstract available


  6. SHAGISULTANOVA E, Parris H, Liu L, Giangiuli S, et al
    Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2025 Jun 11:S1526-8209(25)00167.
    PubMed     Abstract available


  7. ZHU R, Qiu J, Xian D, Yang K, et al
    The Role of 473 Intestinal Microbiota and 91 Inflammatory Factors in Breast Cancer Risk: Insights From Mendel Randomization and its Implications for Diagnosis and Treatment.
    Clin Breast Cancer. 2025 Jun 11:S1526-8209(25)00164.
    PubMed     Abstract available


  8. TURAN V, Oktem O, Bang H, Oktay KH, et al
    Utilization and Fertility Preservation Outcomes in Women Undergoing Embryo Cryopreservation Before Breast Cancer Treatment: A Meta-Analysis.
    Clin Breast Cancer. 2025 Jun 8:S1526-8209(25)00165.
    PubMed     Abstract available


  9. MORAES FCA, Wagner PHS, da Silva ABN, Matheus GTFU, et al
    Adjuvant Chemotherapy in Early Triple-Negative Breast Cancer (T1a-c N0M0): A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025 Jun 6:S1526-8209(25)00163.
    PubMed     Abstract available


  10. BRUNETTI N, Campi C, Piana M, Picone I, et al
    A Radiomic and Clinical Data-Based Risk Model for Malignancy Prediction of Breast BI-RADS 4A Microcalcifications.
    Clin Breast Cancer. 2025;25:e461-e469.
    PubMed     Abstract available


  11. MARCADET J, Bouche C, Arellano C, Gauroy E, et al
    Is Immediate Breast Reconstruction an Option for Elderly Women? A Comparative Study Between Elderly and Younger Population.
    Clin Breast Cancer. 2025;25:e440-e449.
    PubMed     Abstract available


  12. QUINN RM, Bernal AM, Oh SY, Anampa JD, et al
    Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019.
    Clin Breast Cancer. 2025;25:e394-e402.
    PubMed     Abstract available


    May 2025
  13. SHEN WR, Chen SL, Zhang ZZ
    Letter to the Editor Regarding the Article "In Triple-Negative Breast Cancer: Correlation Among Metabolic Syndrome, S100A7/cPLA2 Expression and the Efficacy of Neoadjuvant Chemotherapy".
    Clin Breast Cancer. 2025 May 30:S1526-8209(25)00147.
    PubMed    


  14. CABELLO AERDS, Cabello C, Duarte BN, Alem CER, et al
    Distribution of HER2 Low in Tumors of Patients With Hereditary Breast Cancer According to Germline Pathogenic or Likely Pathogenic Genetic Variants.
    Clin Breast Cancer. 2025 May 28:S1526-8209(25)00148.
    PubMed     Abstract available


  15. SCHNELL PM, Kassem M, Miah A, Ramaswamy B, et al
    Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I-IV Breast Cancer.
    Clin Breast Cancer. 2025 May 27:S1526-8209(25)00161.
    PubMed     Abstract available


  16. WERUTSKY G, Rosa DD, Reinert T, Barroso-Sousa R, et al
    Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
    Clin Breast Cancer. 2025 May 27:S1526-8209(25)00162.
    PubMed     Abstract available


  17. VETTER M, Holer L, Rothgiesser K, Schonfeld W, et al
    Final Overall Survival Analysis of the Phase II SAKK 21/12 Trial of Transdermal CR1447 in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2025 May 24:S1526-8209(25)00146.
    PubMed     Abstract available


  18. HERRAN M, Zabor EC, Sabbagh S, Bilani N, et al
    Disparities in Access to Multigene Testing in Early-Stage, HR-positive, HER2-negative, Lymph Node-negative Breast Cancer.
    Clin Breast Cancer. 2025 May 24:S1526-8209(25)00149.
    PubMed     Abstract available


  19. KINSEY-TROTMAN S, Nguyen A, Edwards S, Swalling A, et al
    Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025 May 22:S1526-8209(25)00144.
    PubMed     Abstract available


  20. GAO D, Yongjia Z, Gao Y, Zeng L, et al
    MRI Response Pattern of Breast Invasive Micropapillary Carcinoma After Neoadjuvant Chemotherapy: A Matched Cohort Study With Invasive Breast Cancer of no Special Type.
    Clin Breast Cancer. 2025 May 22:S1526-8209(25)00145.
    PubMed     Abstract available


  21. ANAMPA JD, Soto AA, Lin S, Bernal AM, et al
    Use and Benefit of Neoadjuvant Versus Adjuvant Chemotherapy in Node-Negative, T1 Triple Negative Breast Cancer.
    Clin Breast Cancer. 2025 May 21:S1526-8209(25)00142.
    PubMed     Abstract available


  22. YANG Y, Shao B, Wei C, Zhang X, et al
    Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2025 May 20:S1526-8209(25)00134.
    PubMed     Abstract available


  23. MORGANTI S, Chu X, Ballinger TJ, Unni N, et al
    A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2025 May 16:S1526-8209(25)00133.
    PubMed     Abstract available


  24. LOBO-MARTINS S, Debien V, Agostinetto E, Sirico M, et al
    Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.
    Clin Breast Cancer. 2025 May 15:S1526-8209(25)00115.
    PubMed     Abstract available


  25. HEELING E, van de Kamer JB, Bruining A, Pluim JME, et al
    The Safe Use of (125)I-Seeds as a Surgical Localization Technique for Breast Cancer Patients During Breastfeeding and Close Contact With an Infant.
    Clin Breast Cancer. 2025 May 14:S1526-8209(25)00132.
    PubMed     Abstract available


  26. ELENA CM, Fulvia PF, Emanuela R, Luigi C, et al
    A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor
    Clin Breast Cancer. 2025 May 13:S1526-8209(25)00116.
    PubMed     Abstract available


  27. ZHANG JN, Zhou XR, Yi ZL, Tian XY, et al
    The Construction of a New Prognostic Model of Breast Cancer and the Exploration of Drug Sensitivity Based on Machine Learning for Glycosylation-Related Genes.
    Clin Breast Cancer. 2025 May 10:S1526-8209(25)00117.
    PubMed     Abstract available


  28. NEPUTE JA, Peratikos M, Toledano AY, Salvas JP, et al
    Improved Breast Cancer Detection with Artificial Intelligence in a Real-World Digital Breast Tomosynthesis Screening Program.
    Clin Breast Cancer. 2025 May 9:S1526-8209(25)00120.
    PubMed     Abstract available


  29. VELLAN CJ, Natesan V, Jayapalan JJ
    Metabolomics Biomarkers for Breast Cancer: An updated perspective.
    Clin Breast Cancer. 2025 May 8:S1526-8209(25)00118.
    PubMed     Abstract available


  30. CHEN L, Su Y, Wang Y, Yu Y, et al
    Ultrasound Radiomics-Based Machine Learning and SHapley Additive exPlanations Method Predicting Pathological Prognostic Stage in Breast Cancer: A Bicentric and Validation Study.
    Clin Breast Cancer. 2025 May 8:S1526-8209(25)00114.
    PubMed     Abstract available


  31. MATUSZ-FISHER A, Chen A, Donahue EE, Schepel CR, et al
    Clinical outcomes by histologic pattern of early-stage metaplastic breast cancer: A single-institution retrospective study.
    Clin Breast Cancer. 2025 May 3:S1526-8209(25)00113.
    PubMed     Abstract available


  32. LI Y, Sundquist K, Wang X, Sundquist J, et al
    The Mitochondrial Signature for Predicting Outcome of Early-Stage Breast Cancer by Machine Learning.
    Clin Breast Cancer. 2025 May 3:S1526-8209(25)00110.
    PubMed     Abstract available


  33. O'SHAUGHNESSY J, Sousa S, Cruz J, Fallowfield DL, et al
    Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study.
    Clin Breast Cancer. 2025 May 3:S1526-8209(25)00107.
    PubMed     Abstract available


  34. WU CH, Chang MH, Chen HJ, Tsai HH, et al
    Artificial Intelligence-Based Automatic Mitosis Scoring in Breast Cancer Improves Inter-Observer Concordance and Efficiency.
    Clin Breast Cancer. 2025 May 1:S1526-8209(25)00112.
    PubMed     Abstract available


    April 2025
  35. PAIVA CE, Guimaraes VS, Silva ATF, Maia YCP, et al
    Navigating Endocrine Sensitivity Assessment in Nonmetastatic Breast Cancer Through Early On-Treatment Ki67 Understanding.
    Clin Breast Cancer. 2025 Apr 30:S1526-8209(25)00111.
    PubMed     Abstract available


  36. KIM JJ, Kim JY, Hwangbo L, Lee H, et al
    Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores.
    Clin Breast Cancer. 2025 Apr 29:S1526-8209(25)00105.
    PubMed     Abstract available


  37. BERNER-WYGODA Y, Li M, Perlon C, Malon D, et al
    Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2025 Apr 28:S1526-8209(25)00108.
    PubMed     Abstract available


  38. ASPHAUG L, Akslen LA, Blix ES, Boge B, et al
    Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
    Clin Breast Cancer. 2025 Apr 15:S1526-8209(25)00102.
    PubMed     Abstract available


  39. SONG Y, Wang C, Zhou Y, Sun Q, et al
    A Multi-Omics-Based Prognostic Model for Elderly Breast Cancer by Machine Learning: Insights From Hypoxia and Immunity of Tumor Microenvironment.
    Clin Breast Cancer. 2025 Apr 15:S1526-8209(25)00099.
    PubMed     Abstract available


  40. JABER D, Vaziri T, Beckerman J, Sen M, et al
    Breast Cancer Clinical Characteristics, Management, and Outcomes in Women Living With HIV/AIDS Globally: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2025 Apr 11:S1526-8209(25)00086.
    PubMed     Abstract available


  41. XU Q, Gao Y
    Letter to the Editor Regarding the Article "The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment of Breast Cancer at a Community Hospital".
    Clin Breast Cancer. 2025 Apr 10:S1526-8209(25)00100.
    PubMed    


  42. SOLANO OI, Withers C, Allen K, Baliski C, et al
    Patient Reported Outcomes in Breast Cancer: A Plea for the Silent and Forgotten.
    Clin Breast Cancer. 2025 Apr 10:S1526-8209(25)00097.
    PubMed     Abstract available


  43. GABA AG, Cao L, Renfrew RJ, Sahmoun AE, et al
    Impact of Racial Disparities on Treatment of Early Triple Negative Breast Cancer Among American Indians/Alaska Natives and Non-Hispanic Whites.
    Clin Breast Cancer. 2025 Apr 9:S1526-8209(25)00093.
    PubMed     Abstract available


  44. JHAVERI K, Anders CK, Bardia A, Bhave M, et al
    Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.
    Clin Breast Cancer. 2025 Apr 8:S1526-8209(25)00098.
    PubMed     Abstract available


  45. LABIDI S, Mulla N, Elkholi IE, Capella MP, et al
    High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer.
    Clin Breast Cancer. 2025 Apr 7:S1526-8209(25)00092.
    PubMed     Abstract available


  46. SHAO C
    Lack of Mechanistic Validation in Breast Cancer: Necessity of NF-kappaB Remains Unclear.
    Clin Breast Cancer. 2025 Apr 5:S1526-8209(25)00095.
    PubMed    


  47. REYES A, Rao R, Wiechmann L, Sun L, et al
    Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy.
    Clin Breast Cancer. 2025 Apr 3:S1526-8209(25)00089.
    PubMed     Abstract available


  48. PELZL CE, Drake A, Patel BK, Rula EY, et al
    Mobile Mammography Utilization and Breast Cancer Screening Adherence Among Medicare Fee-for-Service Beneficiaries.
    Clin Breast Cancer. 2025;25:e288-e300.
    PubMed     Abstract available


  49. LIN YC, Lui SA, Chen MY, Chou YY, et al
    Safety and Feasibility of Robotic Nipple-Sparing Mastectomy With Immediate Direct-to-Implant Reconstruction - Insights From the One of the Largest Centers in Asia.
    Clin Breast Cancer. 2025;25:277-282.
    PubMed     Abstract available


  50. VOUTSADAKIS IA
    Breast Cancers With Intermediate Estrogen Receptor Expression: Characteristics, Prognosis and Treatment.
    Clin Breast Cancer. 2025;25:214-222.
    PubMed     Abstract available


  51. MEILLAN N, Rivera S, Ederhy S, Gueiderikh A, et al
    Early Breast Cancer Treatment and Cardiac Events: A Systematic Review.
    Clin Breast Cancer. 2025 Apr 1:S1526-8209(25)00085.
    PubMed     Abstract available


    March 2025
  52. MITRI S, Manfroi LM, Pannu PR, Means J, et al
    Optimizing Axillary Management in Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2025 Mar 31:S1526-8209(25)00088.
    PubMed     Abstract available


  53. LIAN J, Yao R, Pang S, Ren X, et al
    Comprehensive analysis of HER2 Low Breast Cancer Response to Neoadjuvant Chemotherapy, a Retrospective Cohort Study.
    Clin Breast Cancer. 2025 Mar 25:S1526-8209(25)00081.
    PubMed     Abstract available


  54. QIU J, Shen Z, Jiang G, Ni Q, et al
    Study on Heparanase Promoting Breast Cancer Cell Proliferation and Inhibiting NK Cell Cytolytic Activity Via the PD-1/PD-L1 Pathway.
    Clin Breast Cancer. 2025 Mar 24:S1526-8209(25)00080.
    PubMed     Abstract available


  55. DE MORAES FCA, Sano VKT, Pereira CRM, de Laia EA, et al
    Effects of AKT Inhibitors for PIK3CA/AKT1/PTEN-Altered Advanced or Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials.
    Clin Breast Cancer. 2025 Mar 20:S1526-8209(25)00079.
    PubMed     Abstract available


  56. DONG T, Zhou H, Tang J
    The Tumor-Suppressive Role of miR-204-5p Through Targeting Ezrin in Breast Cancer: Experimental Evidence From Cell Lines and Clinical Samples.
    Clin Breast Cancer. 2025 Mar 19:S1526-8209(25)00042.
    PubMed     Abstract available


  57. GUZIK G, Kurian M, Patell K, Trybula M, et al
    A Review of Current Literature and Real-World Outcomes With Neoadjuvant Chemotherapy in Hormone Receptor Positive, HER2 Negative Breast Cancer.
    Clin Breast Cancer. 2025 Mar 12:S1526-8209(25)00067.
    PubMed     Abstract available


  58. KULKARNI SE, Patel SA, Jiang C, Schwieger L, et al
    Postmastectomy Radiation Therapy for Intermediate-Risk Breast Cancer Patients With 0-3 Positive Axillary Lymph Nodes: Emulating the SUPREMO Trial Using Real-World Data.
    Clin Breast Cancer. 2025 Mar 11:S1526-8209(25)00066.
    PubMed     Abstract available


  59. FRANCA FC, de Oliveira-Junior I, Vieira RADC
    Forequarter Amputation for Breast Cancer. Systematic Review and Survival Analysis.
    Clin Breast Cancer. 2025 Mar 10:S1526-8209(25)00051.
    PubMed     Abstract available


  60. HUSSAIN MS, Ramalingam PS, Chellasamy G, Yun K, et al
    Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer.
    Clin Breast Cancer. 2025 Mar 8:S1526-8209(25)00052.
    PubMed     Abstract available


  61. BRUMER RP, Angarita FA
    Perioperative Considerations of Breast Cancer Neoadjuvant Treatments.
    Clin Breast Cancer. 2025 Mar 7:S1526-8209(25)00050.
    PubMed     Abstract available


  62. ENLUND M
    It Does Not Matter Which Anesthetic We Use for Long-Term Survival After Breast Cancer Surgery.
    Clin Breast Cancer. 2025 Mar 5:S1526-8209(25)00044.
    PubMed    


  63. KIM H, Kang J, Park H, Chun Y, et al
    Comparing the Combination of Clinical Risk and Ki-67 Using EndoPredict as an Alternative to Multigene Assays in Prognostic Evaluation of Breast Cancer.
    Clin Breast Cancer. 2025 Mar 5:S1526-8209(25)00045.
    PubMed     Abstract available


  64. GARUFI G, Mastrantoni L, Maliziola N, Monte ED, et al
    Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study.
    Clin Breast Cancer. 2025 Mar 5:S1526-8209(25)00046.
    PubMed     Abstract available


  65. LIN N, Abbas-Aghababazadeh F, Su J, Wu AJ, et al
    Development of Machine Learning Models for Predicting Radiation Dermatitis in Breast Cancer Patients Using Clinical Risk Factors, Patient-Reported Outcomes, and Serum Cytokine Biomarkers.
    Clin Breast Cancer. 2025 Mar 5:S1526-8209(25)00048.
    PubMed     Abstract available


  66. CHOU KN, Park DJ, Hori YS, Emrich SC, et al
    Primary Stereotactic Body Radiation Therapy for Breast Cancer Spinal Metastases.
    Clin Breast Cancer. 2025 Mar 4:S1526-8209(25)00047.
    PubMed     Abstract available


  67. KAHRAMAN S, Erul E, Gumusay O, Guven DC, et al
    Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic?Breast Cancer: Turkish Oncology Group (TOG) Study.
    Clin Breast Cancer. 2025 Mar 4:S1526-8209(25)00049.
    PubMed     Abstract available


    February 2025
  68. MA C, Fang X, Wang W, Ji S, et al
    In Triple-Negative Breast Cancer: Correlation Among Metabolic Syndrome, S100A7/cPLA2 Expression and the Efficacy of Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2025 Feb 28:S1526-8209(25)00043.
    PubMed     Abstract available


  69. LI C, Du C
    Enhancing the Assessment of Breast Cancer Surgery Information on YouTube.
    Clin Breast Cancer. 2025 Feb 20:S1526-8209(25)00039.
    PubMed    


  70. YANG H, Xie X, Lin L, Tan Z, et al
    Relationship Between Chronic Pain and Breast Cancer: Insight From Genetic Correlation Analyses and 2-Sample Mendelian Randomization.
    Clin Breast Cancer. 2025 Feb 18:S1526-8209(25)00032.
    PubMed     Abstract available


  71. VASCONCELLOS JM, Bonadio RC, Mendes SV, Orsi BZ, et al
    Does Undertreatment With Chemotherapy Impact the Outcomes of Elderly Patients With Early-Stage Breast Cancer? A Real-World Data Analysis.
    Clin Breast Cancer. 2025 Feb 18:S1526-8209(25)00036.
    PubMed     Abstract available


  72. FISCHER U
    Tumor Growth Rate of Luminal and Nonluminal Invasive Breast Cancer Calculated on MRI Imaging.
    Clin Breast Cancer. 2025 Feb 18:S1526-8209(25)00037.
    PubMed     Abstract available


  73. MACK M, McGee M, Bennie B, Arenz A, et al
    The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment of Breast Cancer at a Community Hospital.
    Clin Breast Cancer. 2025 Feb 14:S1526-8209(25)00034.
    PubMed     Abstract available


  74. WU J, Yang J, Duan J
    Anesthetic Agents as Therapeutic Tools in Breast Cancer: Insights into Cancer Progression and Recurrence.
    Clin Breast Cancer. 2025 Feb 13:S1526-8209(25)00038.
    PubMed     Abstract available


  75. WANG J, Wang X, He Y, Wang T, et al
    Comparison of 10-Year Survival Between Patients With Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy and Patients With Initially Negative Nodes in Breast Cancer.
    Clin Breast Cancer. 2025 Feb 12:S1526-8209(25)00035.
    PubMed     Abstract available


  76. FLEEGE NMG, Loeffler BT, Boehnke KF, Henry NL, et al
    Characterizing Cannabidiol Use in a Breast Cancer Population.
    Clin Breast Cancer. 2025 Feb 7:S1526-8209(25)00033.
    PubMed     Abstract available


  77. XIANG X, Lu X, He M, Gou Z, et al
    Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study.
    Clin Breast Cancer. 2025 Feb 6:S1526-8209(25)00030.
    PubMed     Abstract available


  78. LI ZY, Wu SN, Lin P, Jiang MC, et al
    Habitat-Based Radiomics for Revealing Tumor Heterogeneity and Predicting Residual Cancer Burden Classification in Breast Cancer.
    Clin Breast Cancer. 2025 Feb 4:S1526-8209(25)00028.
    PubMed     Abstract available


  79. KOOK Y, Kim JH, Jang JS, Bae SJ, et al
    Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort Study.
    Clin Breast Cancer. 2025;25:164-171.
    PubMed     Abstract available


  80. HACKING SM, Wu D, Taneja C, Graves T, et al
    Is Axillary Lymph Node Dissection Needed? Clinicopathological Correlation in a Series of 224 Neoadjuvant Chemotherapy-Treated Node-Positive Breast Cancers.
    Clin Breast Cancer. 2025;25:172-179.
    PubMed     Abstract available


  81. DIGREGORIO N, Munter-Young R
    Developing & Validating a Clinical Decision Support Tool for ER-Targeted PET Imaging With 16alpha-18F-Fluoro-17beta-Fluoroestradiol.
    Clin Breast Cancer. 2025;25:133-140.
    PubMed     Abstract available


  82. CHA E, Ambinder EB, Oluyemi ET, Mullen LA, et al
    Clinical and Imaging Features Associated With Malignant Focal Nonmass Enhancement on Breast MRI.
    Clin Breast Cancer. 2025;25:157-163.
    PubMed     Abstract available


  83. GONIMA VALERO E, Rodriguez Miranda CD, Contreras Arrieta S, Daza Morelli MI, et al
    Nonpharmacological Interventions for Postmastectomy Pain Syndrome-A Systematic Review of the Literature.
    Clin Breast Cancer. 2025;25:e133-e151.
    PubMed     Abstract available


  84. WU T, Chen J, Shao S, Du Y, et al
    Prediction of Microinvasion in Breast Ductal Carcinoma in Situ Using Conventional Ultrasound Combined with Contrast-Enhanced Ultrasound Features: A Two-Center Study.
    Clin Breast Cancer. 2025;25:e178-e189.
    PubMed     Abstract available


  85. VICINI F, Shah C, Mittal K, Abraham J, et al
    A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation Therapy.
    Clin Breast Cancer. 2025;25:e152-e158.
    PubMed     Abstract available


    January 2025
  86. YOUSSRY S, Hussein A, Moneim NAE, Samy A, et al
    Evaluation of Neutrophil Activation Biomarkers in Response to Programmed Cell Death Protein-1 (PD-1) and Toll-like Receptor 9 (TLR-9) Inhibition in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2025 Jan 31:S1526-8209(25)00027.
    PubMed     Abstract available


  87. DA SILVA-FILHO PPP, Buttros DAB, Buttros LAB, Esperanca G, et al
    High Risk of Metabolic Dysfunction in Nonobese Breast Cancer Survivors.
    Clin Breast Cancer. 2025 Jan 27:S1526-8209(25)00019.
    PubMed     Abstract available


  88. JIA Y, Gan C, Chai J, Huang R, et al
    The Effect of CALM Intervention on Negative Emotions and Sleep Quality in Patients Undergoing Endocrine Therapy for Breast Cancer.
    Clin Breast Cancer. 2025 Jan 17:S1526-8209(25)00017.
    PubMed    


  89. LIU H, Xia H, Yin X, Qin A, et al
    Study on the Differentiation of Infiltrating Breast Cancer Molecular Subtypes Based on Ultrasound Radiomics.
    Clin Breast Cancer. 2025 Jan 16:S1526-8209(25)00016.
    PubMed     Abstract available


  90. COUSINS L, Darragh L, Kerr B
    Health Information on Breast Cancer Surgery on YouTube(R).
    Clin Breast Cancer. 2025 Jan 15:S1526-8209(25)00013.
    PubMed     Abstract available


  91. KIM MJ, Kim HJ, Kim JY, Shin J, et al
    Effectiveness of Adjuvant Capecitabine in Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Treatment: A Real-World Evidence Study in Korea.
    Clin Breast Cancer. 2025 Jan 13:S1526-8209(24)00369.
    PubMed     Abstract available


  92. GODDING LTH, Dekker-Klaassen A, Volders JH, van Hezewijk M, et al
    The Added Value of Physical Examination for Breast Cancer Recurrence Detection in Women: A Systematic Review.
    Clin Breast Cancer. 2025 Jan 11:S1526-8209(24)00365.
    PubMed     Abstract available


  93. LEONE JP, Moges R, Leone J, Vallejo CT, et al
    Factors Associated With Short- and Long-Term Survival in Metastatic HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2025 Jan 8:S1526-8209(25)00002.
    PubMed     Abstract available


  94. NEUMAN HB, Wilke LG, Bozzuto LM, Stelle L, et al
    Engaging Multidisciplinary Teams to Develop Pragmatic Clinical Practice Guidelines to Support Management of Patients With High-Risk Breast Lesions.
    Clin Breast Cancer. 2025;25:56-64.
    PubMed     Abstract available


  95. LI AC, Hammond S, Crosby D, Li Z, et al
    Clinicopathologic Features and Digital Imaging Analysis of HER2 Protein in Breast Carcinomas With Different HER2 Fluorescence in Situ Hybridization Patterns.
    Clin Breast Cancer. 2025;25:38-45.
    PubMed     Abstract available


  96. YAO Y, Zhao Y, Guo X, Xu X, et al
    Deep Learning for Distinguishing Mucinous Breast Carcinoma From Fibroadenoma on Ultrasound.
    Clin Breast Cancer. 2025;25:75-84.
    PubMed     Abstract available


  97. CRUZ HSS, Verdial FC, Shanno JN, Webster AJ, et al
    Axillary Recurrence in Sentinel Lymph Node Negative Mastectomy Patients at 16 Years Median Follow Up: Natural History in the Absence of Radiation.
    Clin Breast Cancer. 2025;25:e63-e70.
    PubMed     Abstract available


  98. CINISELLI CM, Verderio P, Baili P, Sant M, et al
    Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast.
    Clin Breast Cancer. 2025;25:e79-e85.
    PubMed     Abstract available


    December 2024
  99. PATEL R, Jin C, Jaber D, Casasanta N, et al
    Low Dose Tamoxifen for Breast Cancer Prevention: A Real-World Experience.
    Clin Breast Cancer. 2024 Dec 31:S1526-8209(24)00370.
    PubMed     Abstract available


  100. HINOJO C, Cantos B, Antolin S, Arqueros C, et al
    Identification and Management of Medical Comorbidities in Patients With HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain Opinion.
    Clin Breast Cancer. 2024 Dec 31:S1526-8209(24)00367.
    PubMed     Abstract available


  101. TRAPANI D, Jin Q, Miller KD, Rugo HS, et al
    Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.
    Clin Breast Cancer. 2024 Dec 31:S1526-8209(24)00371.
    PubMed     Abstract available


  102. ZHANG Y, Wang G, Si J, Xu M, et al
    Influence of Postmastectomy Radiotherapy on Overall Survival in Patients With Clinical Prognostic Stage I-III Breast Cancer With Positive Responses and Achieving YPN0 Following Neoadjuvant Therapy: A Propensity Score Matching Based on the SEER Databas
    Clin Breast Cancer. 2024 Dec 19:S1526-8209(24)00358.
    PubMed     Abstract available


  103. CAZZANIGA ME, Huober J, Tamma A, Emde A, et al
    Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer.
    Clin Breast Cancer. 2024 Dec 17:S1526-8209(24)00359.
    PubMed     Abstract available


  104. GOLDFARB SB, Sammons SL, Meisel JL, Pluard TJ, et al
    Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study.
    Clin Breast Cancer. 2024 Dec 13:S1526-8209(24)00339.
    PubMed     Abstract available


  105. THAKUR B, Verma R, Bhatia A
    Mutations in Necroptosis-Related Genes Reported in Breast Cancer: A Cosmic and Uniport Database-Based Study.
    Clin Breast Cancer. 2024 Dec 11:S1526-8209(24)00356.
    PubMed     Abstract available


  106. WANG F, Ren F, Qian J, Xu Y, et al
    Predicting Late Recurrence in Male Estrogen Receptor-Positive Breast Cancer With Clinical Treatment Score Post-5 years: A SEER database analysis of 65,711 cases.
    Clin Breast Cancer. 2024 Dec 10:S1526-8209(24)00357.
    PubMed     Abstract available


  107. KAMARAJU S, Fowler AM, Tarima S, Chaudhary LN, et al
    A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.
    Clin Breast Cancer. 2024 Dec 10:S1526-8209(24)00333.
    PubMed     Abstract available


  108. TAO X, Han J, Li Y, Tian Y, et al
    The Difference of RCB 0 and RCB I in Prognosis of Breast Cancer After Neoadjuvant Therapy: A Meta-Analysis.
    Clin Breast Cancer. 2024 Dec 9:S1526-8209(24)00336.
    PubMed     Abstract available


  109. LEE YW, Baek S, Lee JW, Lee YJ, et al
    Menopausal Symptom Burden in Premenopausal Breast Cancer Patients: Interaction of Chemotherapy and Ovarian Function Suppression on Tamoxifen Treatment.
    Clin Breast Cancer. 2024 Dec 9:S1526-8209(24)00354.
    PubMed     Abstract available


  110. CARLOS OE, Maria P, Miriam C, Catalina F, et al
    Axillary Reverse Mapping Using Indocyanine Green in Breast Cancer: Standardization of the Technique.
    Clin Breast Cancer. 2024 Dec 7:S1526-8209(24)00341.
    PubMed     Abstract available


  111. HUWS AM, Davies GR, Lewis PD, Morgan C, et al
    Comparison of Systemic Inflammatory Indices With the Oncotype DX Recurrence Score and the Nottingam Prognostic Index in Early Hormone Receptor Positive Ductal Breast Cancer.
    Clin Breast Cancer. 2024 Dec 7:S1526-8209(24)00337.
    PubMed     Abstract available


  112. BROWN NL, Tivey A, Frank S, Phua SC, et al
    Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast Cancer.
    Clin Breast Cancer. 2024 Dec 7:S1526-8209(24)00340.
    PubMed     Abstract available


  113. KNOEDLER S, Diatta F, Klimitz FJ, Noel O, et al
    Unveiling Inequities: Racial Disparities in Risk-Reducing Mastectomy for Breast Cancer Prevention.
    Clin Breast Cancer. 2024 Dec 6:S1526-8209(24)00342.
    PubMed     Abstract available


  114. XIONG W, Sun J, Gu Q, Xu T, et al
    Pyrotinib Plus Taxanes or Vinorelbine for the Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Prospective Evaluation of Efficacy and Safety.
    Clin Breast Cancer. 2024 Dec 5:S1526-8209(24)00355.
    PubMed     Abstract available


  115. ALTUNDAG K
    Muscle Quality May Improve With Regular Exercise, Improving the Prognosis for Breast Cancer Patients.
    Clin Breast Cancer. 2024 Dec 5:S1526-8209(24)00343.
    PubMed    


  116. PLEASANT VA, Merajver SD
    Universal Genetic Counseling and Testing for Black Women: A Risk-Stratified Approach to Addressing Breast Cancer Disparities.
    Clin Breast Cancer. 2024 Dec 4:S1526-8209(24)00338.
    PubMed     Abstract available


  117. BHARDWAJ S, Jaffer S
    A Comparative Analysis of the Value of HER2 Immunohistochemistry Scoring in Primary and Metastatic Breast Cancer, in the Era of HER2 "Low" Breast Cancers.
    Clin Breast Cancer. 2024 Dec 4:S1526-8209(24)00331.
    PubMed     Abstract available


  118. ROSALES-REYNOSO MA, Juarez-Vazquez CI, Garcia-Sanchez IN, Palacios-Ramirez A, et al
    Investigation of HOTAIR rs12826786, rs920778 and rs4759314 Variants With Breast Cancer Susceptibility and Clinicopathological Characteristics in a Mexican Population.
    Clin Breast Cancer. 2024 Dec 3:S1526-8209(24)00335.
    PubMed     Abstract available


  119. PAGLIARA D, Serra PL, Pili N, Giardino FR, et al
    Prediction of Mastectomy Skin Flap Necrosis With Indocyanine Green Angiography and Thermography: A Retrospective Comparative Study.
    Clin Breast Cancer. 2024;24:755-762.
    PubMed     Abstract available


  120. SWAIN M, Miller M, Cannella C, Doe S, et al
    A Retrospective Study of Fertility Counseling and Preservation Rates for Women of Reproductive Age With Breast Care After Integrating a Fertility Specialist Into a Multidisciplinary Tumor Board.
    Clin Breast Cancer. 2024;24:e764-e771.
    PubMed     Abstract available


  121. SWANCUTT MM, Marchese CR, Baumgartner BA, Allard AJ, et al
    Characterization of the Posterior Femoral Cutaneous Nerve and Its Clinical Application for Autologous Breast Reconstruction.
    Clin Breast Cancer. 2024;24:721-727.
    PubMed     Abstract available


  122. KNOEDLER S, Jiang J, Moog P, Alfertshofer M, et al
    Preventive Paradox? Postoperative Outcomes After Risk-Reducing Mastectomy and Direct-to-Implant Breast Reconstruction.
    Clin Breast Cancer. 2024;24:746-754.
    PubMed     Abstract available


  123. ZHANG N, Pan L, Weng T, Li J, et al
    Chemotherapy Combined With Endocrine Therapy: Old Wine in a New Bottle?
    Clin Breast Cancer. 2024;24:e737-e747.
    PubMed     Abstract available


  124. YAO R, Du F, Liu R, Tan L, et al
    Breast Modular Resection (BMR) in Nipple-Sparing Mastectomy (NSM) With Intraoperative Laser Speckle Contrast Imaging (LSCI) Monitoring Improved Surgical Training Outcome Among Fellows.
    Clin Breast Cancer. 2024;24:705-715.
    PubMed     Abstract available


  125. AYUB A, Senol K, Eleftherios M, Cowher MS, et al
    De-Escalating the Extent of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma in Situ Undergoing Mastectomy.
    Clin Breast Cancer. 2024;24:716-720.
    PubMed     Abstract available


  126. O'CONNOR DJ, Davey MG, McFeetors C, McLaughlin RP, et al
    Evaluating Surgical Outcomes Between Estrogen Receptor Positive Invasive Lobular and Invasive Ductal Carcinoma of the Breast-A Propensity Matched Analysis.
    Clin Breast Cancer. 2024;24:e655-e662.
    PubMed     Abstract available


  127. RIIS MLH
    The Challenges of Lobular Carcinomas from a Surgeon's Point of View.
    Clin Breast Cancer. 2024;24:e645-e654.
    PubMed     Abstract available


    November 2024
  128. ABDILLEH K, Aguilar B, Acquaah-Mensah G
    Clinical and Multiomic Features Differentiate Young Black and White Breast Cancer Cohorts Derived by Machine Learning Approaches.
    Clin Breast Cancer. 2024 Nov 28:S1526-8209(24)00321.
    PubMed     Abstract available


  129. ZHANG Q, Li W, Yu S, Xu J, et al
    Heart Rate Variability and Cytokines are Involved in Anxiety in Breast Cancer Patients: A Cross-Sectional Study.
    Clin Breast Cancer. 2024 Nov 28:S1526-8209(24)00322.
    PubMed     Abstract available


  130. RODRIGUES I, Fernandes R, Ferreira A, Pereira D, et al
    Is Progesterone Receptor a Neglected Feature in Breast Cancer? A Retrospective Study Analysing the Clinicopathological Characteristics of Breast Cancer Based on Progesterone Receptor Status.
    Clin Breast Cancer. 2024 Nov 27:S1526-8209(24)00332.
    PubMed     Abstract available


  131. LI G, Huang X, Wu H, Tian H, et al
    Enhancing Early Breast Cancer Diagnosis With Contrast-Enhanced Ultrasound Radiomics: Insights From Intratumoral and Peritumoral Analysis.
    Clin Breast Cancer. 2024 Nov 26:S1526-8209(24)00318.
    PubMed     Abstract available


  132. LIU S, Du B, Zhou S, Shao N, et al
    Patterns of Recurrence and Survival Outcomes of HER2-Low Expression in Early-Stage Breast Cancer.
    Clin Breast Cancer. 2024 Nov 26:S1526-8209(24)00323.
    PubMed     Abstract available


  133. LI L, Liu Z, Chen K, Li Y, et al
    Improving Prognostic Value in Invasive Triple Negative Breast Cancer Through a Combined Nomogram Approach.
    Clin Breast Cancer. 2024 Nov 22:S1526-8209(24)00319.
    PubMed     Abstract available


  134. O'REILLY S, Lynch E, Hwang ES, Brown M, et al
    Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era.
    Clin Breast Cancer. 2024 Nov 21:S1526-8209(24)00317.
    PubMed     Abstract available


  135. KUHLERS SL, Kathol E, Hartnett-Quach D, Krishnamurthy J, et al
    Assessing Outcomes of Tapering 12-Hour and 6-Hour Dexamethasone Prior to Paclitaxel Infusions in Patients With Breast Cancer.
    Clin Breast Cancer. 2024 Nov 17:S1526-8209(24)00314.
    PubMed     Abstract available


  136. WU T, Shi Z, Fida S, Zhou M, et al
    Impact of METTL3/14/16 Gene Polymorphisms on Risk of Breast Cancer in Chinese Women.
    Clin Breast Cancer. 2024 Nov 17:S1526-8209(24)00313.
    PubMed     Abstract available


  137. BATTAIOTTO E, d'Ambrosio S, Trapani D, Curigliano G, et al
    Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More Sustainable and Less Toxic Treatments: Time to Debunk the Myth?
    Clin Breast Cancer. 2024 Nov 12:S1526-8209(24)00301.
    PubMed     Abstract available


  138. TERAOKA S, Yamamoto H, Kikuchi S, Horimoto Y, et al
    Plasma-free Amino Acid Profile is Beneficial for Breast Cancer Screening in Women With Dense Breasts.
    Clin Breast Cancer. 2024 Nov 12:S1526-8209(24)00297.
    PubMed     Abstract available


  139. DAUNGSUPAWONG H, Wiwanitkit V
    Madarosis Among Breast Cancer Survivors: Correspondence.
    Clin Breast Cancer. 2024 Nov 8:S1526-8209(24)00298.
    PubMed    


  140. WU M, Lei S, Tang Y, He C, et al
    Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis.
    Clin Breast Cancer. 2024 Nov 6:S1526-8209(24)00300.
    PubMed     Abstract available


    October 2024
  141. ZHANG Y, Zhang M, Yu G, Wang W, et al
    Development and Validation of a Novel Conditional Survival Nomogram for Predicting Real-Time Prognosis in Patients With Breast Cancer Brain Metastasis.
    Clin Breast Cancer. 2024 Oct 28:S1526-8209(24)00294.
    PubMed     Abstract available


  142. AKTAS A, Greiner RS, Flores M, Boselli D, et al
    Association of Skeletal Muscle Mass and Muscle Quality at Diagnosis With Survival in Young Women With Breast Cancer: Retrospective Observational Study.
    Clin Breast Cancer. 2024 Oct 28:S1526-8209(24)00292.
    PubMed     Abstract available


  143. IBRAHIM HS, Albeshan SM, ElRefaei MA
    Transforming Breast Cancer Care and Clinical Outcomes: Local Experience in Yanbu Industrial City, Saudi Arabia.
    Clin Breast Cancer. 2024 Oct 26:S1526-8209(24)00289.
    PubMed     Abstract available


  144. VISWANATHAN A, Ganesh PS, Pathoor NN, Gopal RK, et al
    Letter to the Editor Regarding the Article "The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons' Perspectives".
    Clin Breast Cancer. 2024 Oct 24:S1526-8209(24)00293.
    PubMed     Abstract available


  145. ZHANG X, Zhang P, Chen X, Liu X, et al
    Deubiquitinase OTUD7B Regulates Cell Proliferation in Breast Cancer.
    Clin Breast Cancer. 2024 Oct 22:S1526-8209(24)00279.
    PubMed     Abstract available


  146. SUN Y, Gao L, Zhou X, Wang Z, et al
    Local Recurrence and Survival Outcomes of Multifocal/Multicentric Breast Cancer After Breast Conserving Therapy: A systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2024 Oct 18:S1526-8209(24)00286.
    PubMed     Abstract available


  147. SORAN A, Senol K, Lupinacci K
    Navigating Lymphedema: The Impact of Indocyanine Green Lymphography on Personalized Therapy Outcomes in Breast Cancer Patients.
    Clin Breast Cancer. 2024 Oct 18:S1526-8209(24)00288.
    PubMed     Abstract available


  148. ALTUNDAG K
    Assessing and Comparing the Diagnostic Effectiveness of [(18)F]FDG PET/CT and [(18)F]FDG PET/MRI for Distant Metastases in Breast Cancer Patients With Invasive Lobular Carcinoma Histology: An Ongoing Topic of Debate?
    Clin Breast Cancer. 2024 Oct 18:S1526-8209(24)00290.
    PubMed    


  149. HENNING JW, Boyne DJ, Brenner DR, Carbonell C, et al
    Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, Canada.
    Clin Breast Cancer. 2024 Oct 18:S1526-8209(24)00287.
    PubMed     Abstract available


  150. JAHAN N, Taraba J, Boddicker NJ, Giridhar KV, et al
    Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience.
    Clin Breast Cancer. 2024 Oct 17:S1526-8209(24)00284.
    PubMed     Abstract available


  151. LI X, Yan C, Yun J, Xu X, et al
    USP4/CARM1 Axis Promotes the Malignant Transformation of Breast Cancer Cells by Upregulating SLC7A11 Expression.
    Clin Breast Cancer. 2024 Oct 16:S1526-8209(24)00280.
    PubMed     Abstract available


  152. GUPTA S, Jones JE, Smith-Graziani D
    Disparities in Hereditary Genetic Testing in Patients with Triple Negative Breast Cancer.
    Clin Breast Cancer. 2024 Oct 10:S1526-8209(24)00277.
    PubMed     Abstract available


  153. ZIEGENGEIST JL, Tan AR
    A Clinical Review of Subcutaneous Trastuzumab and the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2024 Oct 9:S1526-8209(24)00283.
    PubMed     Abstract available


  154. NIRAULA S, Gouli S, Baran AM, O'Regan R, et al
    Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival of Patients With Leptomeningeal Disease.
    Clin Breast Cancer. 2024 Oct 5:S1526-8209(24)00278.
    PubMed     Abstract available


  155. JOHNSON MK, Cortina CS, Aldakkak M, Huang CC, et al
    The Use of Sentinel Lymph Node Biopsy in Patients Undergoing Mastectomy for DCIS.
    Clin Breast Cancer. 2024;24:611-619.
    PubMed     Abstract available


  156. WANG C, Frost J, Tang M, Shah R, et al
    Neighborhood Deprivation is Associated With Increased Postoperative Complications After Implant-Based Breast Reconstruction.
    Clin Breast Cancer. 2024;24:604-610.
    PubMed     Abstract available


  157. CHA E, Oluyemi ET, Ambinder EB, Myers KS, et al
    Clinical Outcomes of Benign Concordant MRI-Guided Breast Biopsies.
    Clin Breast Cancer. 2024;24:597-603.
    PubMed     Abstract available


  158. DE VITA R, Mangialardi ML, Pozzi M, Vietti Michelina V, et al
    A Pericardium Bovine Matrix Pocket in DTI Prepectoral Breast Reconstruction.
    Clin Breast Cancer. 2024;24:e613-e621.
    PubMed     Abstract available


  159. MA X, Zhang L, Xiao Q, Huang Y, et al
    Predicting Prognosis of Phyllodes Tumors Using a Mammography- and Magnetic Resonance Imaging-Based Radiomics Model: A Preliminary Study.
    Clin Breast Cancer. 2024;24:e571-e582.
    PubMed     Abstract available


  160. LIU X, Yan G, Pang J, Xiao Z, et al
    The Systemic Immune-Inflammation Index is a Predictor of Chemotherapy Sensitivity and Disease-Free Survival in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    Clin Breast Cancer. 2024 Oct 1:S1526-8209(24)00275.
    PubMed     Abstract available


    September 2024
  161. SHEN F, Liu Q, Wang Y, Chen C, et al
    Comparison of [(18)F] FDG PET/CT and [(18)F]FDG PET/MRI in the Detection of Distant Metastases in Breast Cancer: A Meta-Analysis.
    Clin Breast Cancer. 2024 Sep 28:S1526-8209(24)00272.
    PubMed     Abstract available


  162. COVINGTON MF
    Maximizing Breast Cancer Detection Through Screening: A Comparative Analysis of Imaging-Based Approaches.
    Clin Breast Cancer. 2024 Sep 26:S1526-8209(24)00273.
    PubMed     Abstract available


  163. WANG H, Cao Y, Zhang L, Zhao Q, et al
    RBM15 Drives Breast Cancer Cell Progression and Immune Escape via m6A-Dependent Stabilization of KPNA2 mRNA.
    Clin Breast Cancer. 2024 Sep 26:S1526-8209(24)00265.
    PubMed     Abstract available


  164. TURAN V, Bedoschi G, Lee DY, Barbosa CP, et al
    Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer.
    Clin Breast Cancer. 2024 Sep 23:S1526-8209(24)00270.
    PubMed     Abstract available


  165. LI T, Isautier J, Lee JM, Marinovich ML, et al
    Performance of Digital Breast Tomosynthesis Versus Digital Mammography in Women With a Family History of Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2024 Sep 21:S1526-8209(24)00274.
    PubMed     Abstract available


  166. PREMJI SK, Ruddy KJ, Vierkant RA, Larson N, et al
    Perceptions of Delayed Alopecia Among Breast Cancer Survivors.
    Clin Breast Cancer. 2024 Sep 21:S1526-8209(24)00269.
    PubMed     Abstract available


  167. RELF IRN, Brahmanand T
    Reductions in Chronic Postsurgical Neuropathic Pain and Mechanical Allodynia in Breast Cancer Patients Treated With Laser Acupuncture: A Retrospective Observational Study.
    Clin Breast Cancer. 2024 Sep 20:S1526-8209(24)00264.
    PubMed     Abstract available


  168. ALTUNDAG K
    Is There Any Association Between Multifocal and Multicentric Disease and Survival Outcome in Breast Cancer Patients?
    Clin Breast Cancer. 2024 Sep 18:S1526-8209(24)00268.
    PubMed    


  169. VISWANATHAN A, Pathoor NN, Gopal RK, Ganesh PS, et al
    Letter to the Editor regarding the article "Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study".
    Clin Breast Cancer. 2024 Sep 18:S1526-8209(24)00267.
    PubMed    


  170. LIANG M, Luo Y, Wang X, Chen C, et al
    Breast Cancer Patient Flap Management After Mastectomy: A Best Practice Implementation Project.
    Clin Breast Cancer. 2024 Sep 8:S1526-8209(24)00251.
    PubMed     Abstract available


  171. PREMJI SK, Ruddy KJ, Larson N, Loprinzi CL, et al
    Madarosis Among Breast Cancer Survivors.
    Clin Breast Cancer. 2024 Sep 6:S1526-8209(24)00238.
    PubMed     Abstract available


  172. MARTIN H, Saunders C, Redfern A, Hickey M, et al
    A Dedicated Menopausal After Cancer Clinic May Improve Adherence to Endocrine Therapy For Breast Cancer: A Population Based Study.
    Clin Breast Cancer. 2024 Sep 3:S1526-8209(24)00230.
    PubMed     Abstract available


    August 2024
  173. SATHYAMOORTHI K, Vp A, Venkataramana LY, Prasad D VV, et al
    Enhancing Breast Cancer Survival Prognosis Through Omic and Non-Omic Data Integration.
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00221.
    PubMed     Abstract available


  174. MATTAR A, Cavalcante FP, Antonini M, Zerwes F, et al
    Letter to the Editor of Clinical Breast Cancer, on "Omitting Axillary Lymph Node Dissection is Associated With an Increased Risk of Regional Recurrence in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials"
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00226.
    PubMed    


  175. MORSE RT, Bean NW, Hall J, Deal A, et al
    Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00228.
    PubMed     Abstract available


  176. SHEPPARD VB, Tariq F, Bastiach D, Philips M, et al
    Trust in Black and White Breast Cancer Patients: Opportunities to Enhance Trustworthiness in Cancer Care.
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00231.
    PubMed     Abstract available


  177. KANJANAPAN Y, Anderson W, Smith M, Green J, et al
    Real-World Analysis of Breast Cancer Patients Qualifying for Adjuvant CDK4/6 Inhibitors.
    Clin Breast Cancer. 2024 Aug 29:S1526-8209(24)00234.
    PubMed     Abstract available


  178. WEI Y, Liu P, Liu X, Wang M, et al
    Analysis of the Relationship Between Primary Tumor Site and Clinicopathological Characteristics and Survival Prognosis of Breast Cancer Patients Based on SEER Database.
    Clin Breast Cancer. 2024 Aug 27:S1526-8209(24)00233.
    PubMed     Abstract available


  179. SHAH C, Cherian S
    Deintensification of Locoregional Therapy Following Neoadjuvant Chemotherapy for Breast Cancer: Where do We Go From Here?
    Clin Breast Cancer. 2024 Aug 24:S1526-8209(24)00225.
    PubMed    


  180. STJEPANOVIC N, Kumar S, Jerzak KJ, Trudeau M, et al
    Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2024 Aug 22:S1526-8209(24)00222.
    PubMed     Abstract available


  181. PROSKURIAKOVA E, Aryal BB, Shrestha DB, Valencia S, et al
    Impact of Obesity on Breast Cancer Clinicopathological Characteristics in Underserved US Community Safety-Net Hospital: A Retrospective Single-Center Study.
    Clin Breast Cancer. 2024 Aug 13:S1526-8209(24)00220.
    PubMed     Abstract available


  182. DALY GR, Dowling GP, Said M, Qasem Y, et al
    Impact of Sentinel Lymph Node Biopsy on Management of Older Women With Clinically Node-Negative, Early-Stage, ER+/HER2-, Invasive Breast Cancer: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2024 Aug 8:S1526-8209(24)00212.
    PubMed     Abstract available


  183. HOU H, Fang K, Zhang YL, Mu Q, et al
    Efficacy of a Combination of Functional Exercise and Psychological Interventions in Improving Postoperative Rehabilitation and Intervention Compliance in Patients With Breast Cancer.
    Clin Breast Cancer. 2024 Aug 8:S1526-8209(24)00219.
    PubMed     Abstract available


  184. FILE DM, Abdou Y, Force J, Moore DT, et al
    A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2024 Aug 8:S1526-8209(24)00213.
    PubMed     Abstract available


  185. CARDOSO JHCO, de Lara ICA, Sobreira LER, Lobo AOM, et al
    Omitting Axillary Lymph Node Dissection Is Associated With an Increased Risk of Regional Recurrence in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Clin Breast Cancer. 2024 Aug 8:S1526-8209(24)00211.
    PubMed     Abstract available


  186. TUGRAL A, Akyol M, Colakoglu O, Bakar Y, et al
    Risk Profiling of Breast Cancer-Related Lymphedema (BCRL) in Patients With Breast Cancer Via Using Body Composition and Tissue Dielectric Constant (TDC) Method: A Cross-Sectional Study.
    Clin Breast Cancer. 2024 Aug 6:S1526-8209(24)00218.
    PubMed     Abstract available


  187. HASSING CMS, Tvedskov THF, Kroman N, Knoop AS, et al
    Evaluating the Prognostic Role of the PAM50 Signature and Selected Immune-Related Signatures for Recurrence in Patients With T1abN0 Breast Cancer.
    Clin Breast Cancer. 2024 Aug 6:S1526-8209(24)00215.
    PubMed     Abstract available


  188. KRISHNAN J, Patel A, Roy AM, Alharbi M, et al
    Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.
    Clin Breast Cancer. 2024 Aug 6:S1526-8209(24)00217.
    PubMed     Abstract available


  189. SCHINDLER F, Wuerstlein R, Schinkoethe T, Debes AM, et al
    Changes in Technical Equipment and Patient Perspectives Navigating Towards Enhanced Digitalization in Breast Cancer Across Pre-COVID-19 and Early COVID-19 Eras.
    Clin Breast Cancer. 2024 Aug 6:S1526-8209(24)00216.
    PubMed     Abstract available


  190. ROSENKRANZ KM, Boughey JC
    Locoregional Management of Multiple Ipsilateral Breast Cancers: A Review.
    Clin Breast Cancer. 2024;24:473-480.
    PubMed     Abstract available


  191. ACAR CR, Orguc S
    Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
    Clin Breast Cancer. 2024;24:481-493.
    PubMed     Abstract available


    July 2024
  192. HEEKE AL, Sha W, Feldman R, Fisher J, et al
    The Genomic Landscape of Breast Cancer in Young and Older Women.
    Clin Breast Cancer. 2024 Jul 30:S1526-8209(24)00206.
    PubMed     Abstract available


  193. ALMEIDA ND, Pepin A, Schrand TV, Shekher R, et al
    Re-Evaluating the Omission of Radiation Therapy in Low-Risk Patients With Early-Stage Breast Cancer.
    Clin Breast Cancer. 2024 Jul 30:S1526-8209(24)00205.
    PubMed     Abstract available


  194. TAHMASEBI FARD Z
    Evaluation of the Effect of Menopausal Status and BMI on Polymorphisms in Fas/Fas L and the Risk of Breast Cancer.
    Clin Breast Cancer. 2024 Jul 25:S1526-8209(24)00203.
    PubMed     Abstract available


  195. LUQUE SUAREZ S, Olivares Crespo ME, Brenes Sanchez JM, Herrera de la Muela M, et al
    Immediate Psychological Implications of Risk-Reducing Mastectomies in Women With Increased Risk of Breast Cancer: A Comparative Study.
    Clin Breast Cancer. 2024 Jul 20:S1526-8209(24)00202.
    PubMed     Abstract available


  196. LI C, Malapati SJ, James LP, Hutchins LF, et al
    Racial Disparity in Adherence to Endocrine Therapy among Women with Early-Stage Hormone Receptor Positive Breast Cancer: An Analysis of Arkansas All-Payers Claims Database.
    Clin Breast Cancer. 2024 Jul 17:S1526-8209(24)00207.
    PubMed     Abstract available


  197. ELSAYED L, Reed E, Modi S, Tandra PK, et al
    Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer.
    Clin Breast Cancer. 2024 Jul 17:S1526-8209(24)00184.
    PubMed     Abstract available


  198. KOTHARI R, Doshi M, Chaithanya PK, Ct S, et al
    A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta(R) in Patients With HER2-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2024 Jul 10:S1526-8209(24)00183.
    PubMed     Abstract available


  199. AL-HILLI Z, Weiss A
    Breast Cancer Surgery-Fast-Paced and ever-Changing.
    Clin Breast Cancer. 2024 Jul 10:S1526-8209(24)00191.
    PubMed    


  200. LINARES-RODRIGUEZ M, Blancas I, Rodriguez-Serrano F
    The Predictive Value of Blood-Derived Exosomal miRNAs as Biomarkers in Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2024 Jul 6:S1526-8209(24)00181.
    PubMed     Abstract available


  201. CONNORS C, Al-Hilli Z
    De-escalation of Axillary Surgery After Neoadjuvant Therapy.
    Clin Breast Cancer. 2024;24:385-391.
    PubMed     Abstract available


  202. WEED C, Wang T, Mohan SC, Wang X, et al
    Comparison of Clinical Breast Exam to Breast MRI Surveillance in Patients Following Nipple-Sparing Mastectomy.
    Clin Breast Cancer. 2024;24:457-462.
    PubMed     Abstract available


  203. YI M, Lin Y, Lin Z, Xu Z, et al
    Biopsy or Follow-up: AI Improves the Clinical Strategy of US BI-RADS 4A Breast Nodules Using a Convolutional Neural Network.
    Clin Breast Cancer. 2024;24:e319-e332.
    PubMed     Abstract available


    June 2024
  204. LI X, Yang L, Jiang F, Jiao X, et al
    Integration of Radiomics and Immune-Related Genes Signatures for Predicting Axillary Lymph Node Metastasis in Breast Cancer.
    Clin Breast Cancer. 2024 Jun 25:S1526-8209(24)00179.
    PubMed     Abstract available


  205. CALDEIRA IDS, Giovanini G, Adorno LF, Fernandes D, et al
    Antiapoptotic and Prometastatic Roles of Cytokine FAM3B in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2024 Jun 22:S1526-8209(24)00173.
    PubMed     Abstract available


  206. CHEN AX, Chen X, Li XX, Guo ZY, et al
    Impacts of Tumor Stage at Diagnosis and Adjuvant Therapy on Long-Term Survival Outcomes in Patients With Triple-Negative Breast Cancer Achieving Pathologic Complete Response After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2024 Jun 21:S1526-8209(24)00178.
    PubMed     Abstract available


  207. EL KADDISSI A, Vernerey D, Falcoz A, Mansi L, et al
    Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2024 Jun 19:S1526-8209(24)00171.
    PubMed     Abstract available


  208. ZENG F, Cai W, Lin L, Chen C, et al
    Development of a Preoperative Prediction Model Based on Spectral CT to Evaluate Axillary Lymph Node With Macrometastases in Clinical T1/2N0 Invasive Breast Cancer.
    Clin Breast Cancer. 2024 Jun 18:S1526-8209(24)00174.
    PubMed     Abstract available


  209. SCHULZE JB, Dorner M, Huber M, Jordan KD, et al
    Psychiatric Diagnoses and Their Treatment in Women With Breast Cancer: A Latent Class Analysis of 1062 Inpatients.
    Clin Breast Cancer. 2024 Jun 18:S1526-8209(24)00176.
    PubMed     Abstract available


  210. CASASANTA N, Patel R, Raymond S, Kier MW, et al
    Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS).
    Clin Breast Cancer. 2024 Jun 12:S1526-8209(24)00167.
    PubMed     Abstract available


  211. GUO H, Zhang X, Wang JG, Kalika P, et al
    S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial.
    Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00149.
    PubMed     Abstract available


  212. MALKIELY G, Ashkenazi I, Malkin L, Zohar Y, et al
    Intraoperative diagnosis of breast cancer metastasis in axillary lymph nodes: Cytological Smear vs. Frozen Section.
    Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00150.
    PubMed     Abstract available


  213. VUONG B, Jacinto AI, Chang SB, Kuehner GE, et al
    Contemporary Review of the Management and Treatment of Young Breast Cancer Patients.
    Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00148.
    PubMed     Abstract available


  214. CAZZATO V, Stocco C, Scian A, Bonat Guarini L, et al
    Nipple Reconstruction Using the "Arrow Flap" Technique: Outcomes and Patients Satisfaction.
    Clin Breast Cancer. 2024;24:e226-e231.
    PubMed     Abstract available


  215. HUANG X, Anderson SA, Siegal GP, Wei S, et al
    Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast Carcinoma.
    Clin Breast Cancer. 2024;24:e310-e318.
    PubMed     Abstract available


  216. HUANG Z, Tian H, Luo H, Yang K, et al
    Assessment of Oxygen Saturation in Breast Lesions Using Photoacoustic Imaging: Correlation With Benign and Malignant Disease.
    Clin Breast Cancer. 2024;24:e210-e218.
    PubMed     Abstract available


  217. WILLEN LPA, Spiekerman van Weezelenburg MA, Bruijsten AA, Broos PPHL, et al
    The Role of Magnetic Resonance Imaging in the Preoperative Staging and Treatment of Invasive Lobular Carcinoma.
    Clin Breast Cancer. 2024;24:e266-e272.
    PubMed     Abstract available


  218. MACKENDER E, Dave R, Tudor D, Harvey J, et al
    A Retrospective Audit of the Triage Process Introduced for Breast Referrals Received During the Covid-19 Pandemic.
    Clin Breast Cancer. 2024;24:e219-e225.
    PubMed     Abstract available


  219. TASOULIS MK, Lee HB, Kuerer HM
    Omission of Breast Surgery in Exceptional Responders.
    Clin Breast Cancer. 2024;24:310-318.
    PubMed     Abstract available


  220. ZIEGENGEIST JL, Elmes JB, Strassels SA, Patel JN, et al
    Alpelisib-Induced Diabetic Ketoacidosis: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and Review of the Literature.
    Clin Breast Cancer. 2024;24:e204-e209.
    PubMed     Abstract available


  221. DOLL A, Kopkash K, Baker J
    Emerging Role of Robotic Surgery in the Breast.
    Clin Breast Cancer. 2024;24:286-291.
    PubMed     Abstract available


  222. BUCHHEIT JT, Schacht D, Kulkarni SA
    Update on Management of Ductal Carcinoma in Situ.
    Clin Breast Cancer. 2024;24:292-300.
    PubMed     Abstract available


  223. MARIN C, Weiss A, Gooch JC
    Updates in the Surgical Management of Benign and High-Risk Breast Lesions.
    Clin Breast Cancer. 2024;24:278-285.
    PubMed     Abstract available


    May 2024
  224. CHENG H, Dai Q, Liu G, Tong X, et al
    The Impact of Neoadjuvant Chemotherapy on Patients With T1N0M0 Triple-Negative and HER-2 Positive Breast Cancer: A Retrospective Analysis Based on the SEER Database.
    Clin Breast Cancer. 2024 May 31:S1526-8209(24)00137.
    PubMed     Abstract available


  225. QADIR A, Singh N, Moe AAK, Cahoon G, et al
    Potential of MRI in Assessing Treatment Response After Neoadjuvant Radiation Therapy Treatment in Breast Cancer Patients: A Scoping Review.
    Clin Breast Cancer. 2024 May 31:S1526-8209(24)00136.
    PubMed     Abstract available


  226. MALLOIZEL-DELAUNAY J, Weyl A, Brusq C, Chaput B, et al
    New Strategy for Breast Cancer Related Lymphedema Treatment by Endermology: ELOCS Phase II Randomized Controlled Trial.
    Clin Breast Cancer. 2024 May 22:S1526-8209(24)00122.
    PubMed     Abstract available


  227. MITRI S, Roldan-Vasquez E, Flores R, Pardo J, et al
    Axillary Management Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
    Clin Breast Cancer. 2024 May 21:S1526-8209(24)00121.
    PubMed     Abstract available


  228. ZHANG L, Wang L, Liang R, He X, et al
    An Effective Ultrasound Features-Based Diagnostic Model via Principal Component Analysis Facilitated Differentiating Subtypes of Mucinous Breast Cancer From Fibroadenomas.
    Clin Breast Cancer. 2024 May 17:S1526-8209(24)00120.
    PubMed     Abstract available


  229. KUSTIC D
    Size of Extranodal Extension in the Sentinel Lymph Node as a Predictor of Prognosis in Early-Stage Breast Cancer.
    Clin Breast Cancer. 2024 May 13:S1526-8209(24)00118.
    PubMed     Abstract available


  230. LI N, Xiao C, Li Y, Zhang Y, et al
    Association of Chlamydia trachomatis Infection With Breast Cancer Risk and the Modification Effect of IL-12.
    Clin Breast Cancer. 2024 May 10:S1526-8209(24)00116.
    PubMed     Abstract available


  231. LIU M, Xiang Q, Dai F, Yuan Y, et al
    Comparison of the Pathological Complete Response Rate and Survival Between HER2-Low and HER2-Zero Breast Cancer in Neoadjuvant Chemotherapy Setting: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2024 May 10:S1526-8209(24)00114.
    PubMed     Abstract available


  232. ONDER T, Ates O, Oner I, Karacin C, et al
    Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors.
    Clin Breast Cancer. 2024 May 10:S1526-8209(24)00117.
    PubMed     Abstract available


  233. DALY GR, Dowling GP, Hamza E, AlRawashdeh M, et al
    Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer >/= 70 Years Old?
    Clin Breast Cancer. 2024 May 7:S1526-8209(24)00115.
    PubMed     Abstract available


  234. MESA-CHAVEZ F, Chavarri-Guerra Y, Lopez-Covarrubias AV, Mayette-Villanueva AE, et al
    Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors.
    Clin Breast Cancer. 2024 May 3:S1526-8209(24)00112.
    PubMed     Abstract available


  235. YANG FA, Wu PJ, Su YT, Strong PC, et al
    Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2024 May 1:S1526-8209(24)00113.
    PubMed     Abstract available


    April 2024
  236. KO G, Naganathan G, Reel E, Cleland J, et al
    The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons' Perspectives.
    Clin Breast Cancer. 2024 Apr 25:S1526-8209(24)00111.
    PubMed     Abstract available


  237. WANG L, Liu L, Zhang Z, Li F, et al
    Cost-effectiveness of Sacituzumab Govitecan versus Single-agent Chemotherapy for Patients with Metastatic Triple-Negative Breast Cancer in China.
    Clin Breast Cancer. 2024 Apr 23:S1526-8209(24)00110.
    PubMed     Abstract available


  238. GUAN D, Shi Q, Zheng Y, Zheng C, et al
    Real-World Data on Pathological Response and Survival Outcomes After Neoadjuvant Chemotherapy in HER2-Low Breast Cancer Patients.
    Clin Breast Cancer. 2024 Apr 14:S1526-8209(24)00106.
    PubMed     Abstract available


  239. PEDERSINI R, Buffoni M, Petrelli F, Ghidini A, et al
    Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis.
    Clin Breast Cancer. 2024 Apr 8:S1526-8209(24)00103.
    PubMed     Abstract available


  240. GONCALVES ACN, Amorim RB, Domingues BS, Sousa JVA, et al
    Female Sexual Function Index Adaptation for Breast Cancer Patients (FSFI-BC): Brazilian Portuguese Translation and Cultural Adaptation.
    Clin Breast Cancer. 2024 Apr 8:S1526-8209(24)00105.
    PubMed     Abstract available


  241. VARNIER R, Moskal A, Bodelet C, Peron J, et al
    Implementing Indicators and Trajectories of Return to Work After Breast Cancer Diagnosis: A Mixed-Methods Study Using the French National Healthcare Insurance Database and Stakeholder Consultation.
    Clin Breast Cancer. 2024 Apr 7:S1526-8209(24)00104.
    PubMed     Abstract available


  242. BAUMGARTEN MW, Goemann IM, Scheffel RS, Maia AL, et al
    Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
    Clin Breast Cancer. 2024 Apr 6:S1526-8209(24)00102.
    PubMed     Abstract available


  243. HUANG J, Sun S, Tan Q, Zheng F, et al
    Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.
    Clin Breast Cancer. 2024 Apr 6:S1526-8209(24)00101.
    PubMed     Abstract available


  244. GRUBSTEIN A, Dahan M, Jomar W, Friehmann T, et al
    Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation Carriers, and Gynecomastia.
    Clin Breast Cancer. 2024 Apr 4:S1526-8209(24)00100.
    PubMed     Abstract available


  245. XU D, Wang K, Lin C, Li D, et al
    Can We Do Breast-Conserving Surgery Without Intraoperative Frozen Section of Margin?
    Clin Breast Cancer. 2024;24:191-198.
    PubMed     Abstract available


  246. SFARAD HK, Allweis TM
    Postoperative Complications Following Lumpectomy With Intraoperative X-Ray Radiation Therapy: A Retrospective Comparative Study.
    Clin Breast Cancer. 2024;24:237-242.
    PubMed     Abstract available


  247. NAG S, Berlin L, Hunter K, Bonawitz SC, et al
    Effects of Neoadjuvant Chemotherapy on Autologous and Implant-Based Breast Reconstruction: A Systematic Review and Meta-Analysis of the Literature.
    Clin Breast Cancer. 2024;24:184-190.
    PubMed     Abstract available


  248. DAVEY MG, Tormey S
    Implications of Highly Penetrant Genetic Variants on Breast Surgery.
    Clin Breast Cancer. 2024;24:180-183.
    PubMed     Abstract available


  249. GRZYWACZ VP, Lehrberg AV, Quinn TJ, Zureick AH, et al
    Breast Conserving Therapy for Patients With Prior Cosmetic Implant-Based Breast Augmentation: Outcomes and Comparison Against a Matched Cohort.
    Clin Breast Cancer. 2024;24:227-236.
    PubMed     Abstract available


    March 2024
  250. KONG CY, Williams J, Hemadasa N, Murphy D, et al
    The Introduction of Magtrace(R) Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial Experience, Perspectives, Outcomes and Learning Curves.
    Clin Breast Cancer. 2024 Mar 30:S1526-8209(24)00099.
    PubMed     Abstract available


  251. CORPUZ GS, Kim DK, Kim IE Jr, Rohde CH, et al
    Existing Psychiatric Diagnoses Among Breast Cancer Patients Interact with Outcomes After Autologous and Implant-Based Bilateral Breast Reconstruction: A Propensity Score Matched Analysis.
    Clin Breast Cancer. 2024 Mar 24:S1526-8209(24)00096.
    PubMed     Abstract available


  252. ZHANG M, Zha H, Pan J, Liu X, et al
    Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer.
    Clin Breast Cancer. 2024 Mar 23:S1526-8209(24)00098.
    PubMed     Abstract available


  253. PAN W, Cheng H, Zhang J, Yang Z, et al
    The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.
    Clin Breast Cancer. 2024 Mar 15:S1526-8209(24)00082.
    PubMed     Abstract available


  254. HU Y, Zhu Y, Shi J, Wei X, et al
    Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer.
    Clin Breast Cancer. 2024 Mar 15:S1526-8209(24)00081.
    PubMed     Abstract available


  255. YADAV BS, Dey T
    Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds.
    Clin Breast Cancer. 2024 Mar 14:S1526-8209(24)00080.
    PubMed     Abstract available


  256. HUANG JX, Chen YJ, Wang XY, Huang JH, et al
    Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer.
    Clin Breast Cancer. 2024 Mar 13:S1526-8209(24)00078.
    PubMed     Abstract available


  257. BA ZC, Zhang HX, Liu AY, Zhou XX, et al
    Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
    Clin Breast Cancer. 2024 Mar 13:S1526-8209(24)00079.
    PubMed     Abstract available


  258. DOWNS-CANNER S, Weiss A
    Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer: What the Surgeon Needs to Know.
    Clin Breast Cancer. 2024 Mar 13:S1526-8209(24)00077.
    PubMed     Abstract available


  259. D'ALESSANDRO GS, Munhoz AM, Takeuchi FM, Povedano A, et al
    Is Immediate Breast Reconstruction With a Latissimus Dorsi Myocutaneous Flap Safe for Starting Adjuvant Chemotherapy in Patients With Breast Cancer?
    Clin Breast Cancer. 2024 Mar 10:S1526-8209(24)00076.
    PubMed     Abstract available


  260. CHEN X, Wei X, Yao P, Liu Y, et al
    The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study.
    Clin Breast Cancer. 2024 Mar 8:S1526-8209(24)00028.
    PubMed     Abstract available


  261. CHI Y, Hirachan S, Zhou Y, Bhandari A, et al
    Exploring the Oncogenic Potential of TIMM8A: A Crucial Factor in Breast Cancer Tumorigenesis.
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00049.
    PubMed     Abstract available


  262. STAFFORD L, Sinclair M, Butow P, Hughes J, et al
    Quality of Life Outcomes Associated With Optimization of Treatment by Omitting Radiotherapy in Early Breast Cancer.
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00062.
    PubMed     Abstract available


  263. WEN W, Li Y, Cao X, Li Y, et al
    Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00060.
    PubMed     Abstract available


  264. MICHAELS E, Chen N, Nanda R
    The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC).
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00061.
    PubMed     Abstract available


  265. JIA X, Wang K, Zhuo Q, Zhao Z, et al
    PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety.
    Clin Breast Cancer. 2024 Mar 2:S1526-8209(24)00059.
    PubMed     Abstract available


  266. CAKIT BD, Vural SP
    Short-Term Effects Of Dry Heat Treatment (Fluidotherapy) In The Management Of Breast Cancer Related Lymphedema: A Randomized Controlled Study.
    Clin Breast Cancer. 2024 Mar 1:S1526-8209(24)00056.
    PubMed     Abstract available


    February 2024
  267. LI G, Huang Z, Luo H, Tian H, et al
    Photoacoustic Imaging Radiomics to Identify Breast Cancer in BI-RADS 4 or 5 Lesions.
    Clin Breast Cancer. 2024 Feb 29:S1526-8209(24)00055.
    PubMed     Abstract available


  268. WANG T, Wang J, Zhao W, Pan Y, et al
    Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00054.
    PubMed     Abstract available


  269. FASOLA CE, Graham E, Sha W, Schepel CR, et al
    Assessment of Postmastectomy Radiation Therapy Receipt by Age and Association With Outcomes in Women With Breast Cancer.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00057.
    PubMed     Abstract available


  270. DURAN C, Ward RC, Dibble EH
    (18)F-FES PET/CT for Post-Cryoablation Evaluation of Breast Cancer.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00043.
    PubMed    


  271. MA S, Liu Y, Gao P, Ma R, et al
    Independent Validation of the BRENDA-Score Breast Cancer Prognosis Prediction Tool In Chinese Patients.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00058.
    PubMed     Abstract available


  272. NISHIMURA R, Fujiki Y, Taira T, Miyaki T, et al
    The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
    Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00051.
    PubMed     Abstract available


  273. SASA S, Inoue H, Nakagawa M, Toba H, et al
    Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer.
    Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00052.
    PubMed     Abstract available


  274. JANSSON M, Lindberg J, Rask G, Svensson J, et al
    Stromal Type I Collagen in Breast Cancer: Correlation to Prognostic Biomarkers and Prediction of Chemotherapy Response.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00053.
    PubMed     Abstract available


  275. DEBIEN V, Agostinetto E, Bruzzone M, Ceppi M, et al
    The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00050.
    PubMed     Abstract available


  276. SONDERGAARD SR, Stie M, Bechmann T, Offersen BV, et al
    Through Clinicians Eyes: Use of an In-consultation Patient Decision Aid in Radiation Treatment for Early Breast Cancer. A Qualitative Study.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00045.
    PubMed     Abstract available


  277. LIAO M, Webster J, Coonrod EM, Weilbaecher KN, et al
    BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00047.
    PubMed     Abstract available


  278. DOUGLAS E, Levine B, Ansari A, Ansley K, et al
    Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00044.
    PubMed     Abstract available


  279. JIANG J, Li L, Yin G, Luo H, et al
    A Molecular Typing Method for Invasive Breast Cancer by Serum Raman Spectroscopy.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00048.
    PubMed     Abstract available


  280. LORENTZEN EH, Minami CA
    Avoiding Locoregional Overtreatment in Older Adults With Early-Stage Breast Cancer.
    Clin Breast Cancer. 2024 Feb 13:S1526-8209(24)00042.
    PubMed     Abstract available


  281. DAI L, Yan W, Ren X, Liu D, et al
    Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.
    Clin Breast Cancer. 2024 Feb 7:S1526-8209(24)00039.
    PubMed     Abstract available


  282. SONOLA O
    Re: "Diagnostic Delays in Breast Cancer Among Young Women: An Emphasis on Healthcare Providers" by Costa et al.
    Clin Breast Cancer. 2024 Feb 6:S1526-8209(24)00038.
    PubMed    


  283. PANG J, Yan Z, Tan QT, Allen JC, et al
    Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
    Clin Breast Cancer. 2024 Feb 5:S1526-8209(24)00040.
    PubMed     Abstract available


  284. METIN NO, Balci S, Metin Y, Tasci F, et al
    Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer.
    Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00037.
    PubMed     Abstract available


  285. REYES A, Sun L, Ha R, Desperito E, et al
    A Comprehensive Assessment of Radial Scars on Core Needle Biopsy in Patients with or without Breast Cancer: Upgrade Rate and Implications on Management.
    Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00035.
    PubMed     Abstract available


    January 2024
  286. YOU YH, Kim MK, Lee JY
    Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast Cancer: Comparing With Young and Middle Age Groups.
    Clin Breast Cancer. 2024 Jan 30:S1526-8209(24)00027.
    PubMed     Abstract available


  287. KAVISHAHI NN, Rezaee A, Jalalian S
    The Impact of miRNAs on the Efficacy of Tamoxifen in Breast Cancer Treatment: A Systematic Review.
    Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00026.
    PubMed     Abstract available


  288. MALHOTRA S, Tadros AB
    New Strategies for Locally Advanced Breast Cancer: A Review of Inflammatory Breast Cancer and Nonresponders.
    Clin Breast Cancer. 2024 Jan 21:S1526-8209(24)00009.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.